In a pivotal development amid an ongoing patent dispute, a federal appeals court has turned down Apple’s plea to temporarily halt the ban on importing the latest iterations of the Apple Watch. Consequently, the ban is scheduled to be reinstated on Thursday, posing implications for the availability of the Apple Watch Series 9 and Apple Watch Ultra 2 in the United States.
The ban originally stemmed from a ruling by the US International Trade Commission (ITC) last October, which concluded that specific functionalities in these Apple Watch models, notably the pulse oximeter feature, infringed upon a patent owned by California-based company Masimo.
Apple had been seeking a reprieve from the ban while their appeal against the ITC’s decision was underway. However, Wednesday’s court filing has confirmed that the ban will remain in effect throughout the duration of the appeals process, which is anticipated to span several months.
Apple has received a measure of leniency, as US Customs and Border Protection granted approval for the continued importation of a modified version of their most advanced Apple Watches. These revised timepieces, devoid of the pulse oximeter functionality, will be made available for purchase in both physical stores and online starting Thursday. These watches will still display the Blood Oxygen icon, but clicking on it will reveal that the feature is “no longer available.”
It is important to highlight that customers who have previously acquired an Apple Watch Series 9 or Ultra 2 featuring the pulse oximeter feature will not be affected by this alteration.
In response to the recent ruling, Apple has affirmed its unwavering commitment to the appeal process, firmly believing that the US Court of Appeals for the Federal Circuit should overturn the ITC’s verdict. The company continues to vehemently dispute the ITC’s ruling and the subsequent ban.
On the opposing side of the dispute, Joe Kiani, CEO of Masimo, expressed contentment with the decision to terminate the temporary pause on the ban.
The legal skirmish between Apple and Masimo has garnered significant attention due to its potential ramifications for patent rights and intellectual property within the technology sector. As both corporations continue to assert their positions, consumers will closely monitor the evolution of this dispute and its potential impact on the future of wearable technology.
With the imminent resumption of the import ban on advanced Apple Watch models, Apple faces challenges in sustaining its product lineup and fulfilling consumer demand while the legal proceedings continue to unfold.